Tuesday, April 22nd, 2025

Author: minichart

XL Axiata Q4 2024 Results: 93% NPAT Growth and Positive Outlook for 2025

Deep Dive Financial Analysis of XL Axiata – February 2025 Deep Dive Financial Analysis of XL Axiata Date: February 7, 2025 Broker: UOB Kay Hian Overview UOB Kay Hian’s latest report dives into the...

Top Glove Stock Analysis: US Tariffs Boost Malaysian Glove Makers’ Prospects in 2025

Top Glove Corp Bhd: Detailed Financial and Market Analysis Top Glove Corp Bhd: A Comprehensive Financial and Market Analysis Broker Name: UOB Kay Hian Date: February 7, 2025 Introduction to Top Glove Corp Bhd...

Plover Bay Technologies: Strong Growth Potential Despite US Tariff Concerns | 35% Profit Growth Forecast

In-Depth Analysis of Plover Bay, JBM Healthcare, and Jacobson Pharma Comprehensive Investment Insights: Plover Bay, JBM Healthcare, and Jacobson Pharma Date: Friday, 07 February 2025 Broker: UOB Kay Hian Plover Bay Technologies: Riding Through...

BAT Malaysia 2024 Results: Mixed Outlook Amid New Nicotine Regulations

British American Tobacco Bhd Analysis – Comprehensive Financial Insights British American Tobacco Bhd: Comprehensive Financial Insights Broker: UOB Kay Hian Date: Friday, 07 February 2025 Overview of British American Tobacco Bhd British American Tobacco...

Bangchak Sriracha (BSRC) Stock: Attractive Buy Opportunity Despite Expected Q4 Loss

Bangchak Sriracha (BSRC): In-Depth Financial Analysis and Market Insights Bangchak Sriracha (BSRC): In-Depth Financial Analysis and Market Insights Date: February 7, 2025 Broker: UOB Kay Hian Company Overview: Bangchak Sriracha (BSRC) Bangchak Sriracha, previously...

Bangchak Corporation (BCP) Q4 2024 Preview: Strong Earnings Growth and Positive 2025 Outlook

Bangchak Corporation: A Comprehensive Analysis of Thailand’s Leading Refinery Bangchak Corporation: A Comprehensive Analysis of Thailand’s Leading Refinery Broker Name: UOB Kay Hian Date of Report: February 7, 2025 Introduction to Bangchak Corporation (BCP)...

Aier Eye Hospital Group: Market Leader Facing Headwinds in China’s Ophthalmology Sector

Análisis Financiero de Aier Eye Hospital Group y su Sector Análisis Financiero Detallado: Aier Eye Hospital Group y el Mercado de Servicios Oftalmológicos Fecha del informe: 7 de febrero de 2025 Broker: UOB Kay...

Wilmar International Q4 2024 Preview: Recovery Expected Despite China Challenges

Wilmar International: Comprehensive Financial Analysis by UOB Kay Hian Wilmar International: In-Depth Financial Analysis and Outlook Report by: UOB Kay Hian Date: February 7, 2025 Overview of Wilmar International Wilmar International is a global...

Singapore Exchange (SGX) Reports Record Earnings: All Business Segments Drive Growth in 1HFY25

Singapore Exchange (SGX) Analysis: Record-High Earnings and Future Outlook Singapore Exchange (SGX) Analysis: Record-High Earnings and Future Outlook Broker Name: UOB Kay Hian Date of Report: Friday, 07 February 2025 Introduction The Singapore Exchange...

SPDR Straits Times Index ETF Announces S$0.091 Dividend Distribution for February 2025

SPDR Straits Times Index ETF Announces Dividend Payout Amid Key Updates SPDR Straits Times Index ETF Announces Dividend Payout Amid Key Updates State Street Global Advisors Singapore Limited, the manager of the SPDR® Straits...